Clinical Trial Update: Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy [Phase 2]

View source ↗

Summary

This clinical trial update reports a completed Phase 2 study evaluating valproic acid and L-carnitine in patients with Spinal Muscular Atrophy, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• L-carnitine (L-carnitine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University of Utah | Conditions: Spinal Muscular Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2011-05-03